Anti-tumour immunity

Show results for

Unknown (487)
Genomics (107)
Transcriptomics (95)
Proteomics (25)
Other (7)
Models (2)
Metabolomics (2)
Clinical (1)
Methylation profiling (1)

Organisms

Mus musculus (69)
Homo sapiens (53)
Archaea (19)
Bacteria (19)
Betaherpesvirinae (19)
Borrelia (19)
Botrytis cinerea (19)
Candida albicans (19)
Clostridium perfringens (19)
Cnidaria (19)
Eukaryota (19)
Fasciola (19)
Fungi (19)
Hepatitis B virus (19)
Human betaherpesvirus 5 (19)
Influenza C virus (19)
Japanese encephalitis virus group (19)
Miscanthus x giganteus (19)
Mycobacterium tuberculosis (19)
Orthoflavivirus (19)
Panicum virgatum (19)
Platyhelminthes (19)
Rattus (19)
Saccharomyces cerevisiae (19)
Salmonella enterica subsp. enterica (19)
Schizosaccharomyces pombe (19)
Sus scrofa (2)
Vesicular stomatitis virus (1)
Solanum lycopersicum (1)
Rattus rattus (1)

Organisms

Mus musculus (54)
Homo sapiens (22)
Muroidea (1)
Bacteria (1)

Repository

ENA (95)
geo (77)
biostudies-arrayexpress (32)
pride (19)
EGA (7)
iProX (5)
BioModels (2)
MetaboLights (2)

Tissue

Cell culture (5)
Macrophage (3)
Bone marrow (2)
Colon (2)
Epithelial cell (2)
Fibroblast (2)
Melanocyte (2)
Primary cell (2)
Skin (2)
Blood (1)
Hepatocyte (1)
Leukocyte (1)
Liver (1)
Lymph node (1)
Spleen (1)
T cell (1)

Disease

Melanoma (3)
Colon cancer (2)
Skin cancer (1)
Cancer (1)
Control (1)
Carcinoma, Renal Cell (1)
Disease free (1)
Head and neck squamous cell carcinoma (1)
Hepatoblastoma (1)
Hepatocellular carcinoma (1)
Skin melanoma (1)

Technology Type

Mass Spectrometry (19)
Shotgun proteomics (9)
Affinity purification coupled with mass spectrometry proteomics (5)
Bottom-up proteomics (4)
SWATH MS (3)
Data-dependent acquisition (2)
Data-independent acquisition (2)
ILLUMINA, Illumina HiSeq 2500 (1)
Mass spectrometry (1)
Mass spectrometry assay (1)

Instrument Platform

Illumina NovaSeq 6000 (3)
Illumina HiSeq 4000 (2)
BD Influx (1)
Illumina NovaSeq X (1)
BGISEQ-500 (1)
NextSeq 500 (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2023 (26)
2025 (25)
2026 (20)
2024 (15)
2020 (9)
2021 (6)
2012 (6)
2022 (4)
2014 (3)
2013 (3)
2008 (3)
2019 (3)
2017 (2)
2010 (2)
2016 (1)
2015 (1)
2011 (1)
2009 (1)
2004 (1)
2018 (1)

UNIPROT ID/AC

P60568 (1)

CHEBI ID

CHEBI:16865 (2)
CHEBI:58115 (2)
CHEBI:16856 (2)
CHEBI:6650 (2)
CHEBI:18012 (2)
CHEBI:15741 (2)
CHEBI:176760 (1)
CHEBI:57746 (1)
CHEBI:58003 (1)
CHEBI:46960 (1)
CHEBI:233489 (1)
CHEBI:84520 (1)
CHEBI:15801 (1)
CHEBI:41941 (1)
CHEBI:57567 (1)
CHEBI:1547 (1)
CHEBI:17141 (1)
CHEBI:17485 (1)
CHEBI:456215 (1)
CHEBI:30865 (1)
CHEBI:132188 (1)
CHEBI:17755 (1)
CHEBI:18261 (1)
CHEBI:35619 (1)
CHEBI:16742 (1)
CHEBI:27570 (1)
CHEBI:22660 (1)
CHEBI:1582 (1)
CHEBI:17376 (1)
CHEBI:1148 (1)

Metabolite Name

Glutathione (2)
Succinic acid (2)
Dihydrooroticacid (1)
Fumaricacid (1)
Guanosine5'-monophosphate (1)
Gamma-Aminobutyric Acid (1)
1-palmitoyl-2-stearoyl-sn-glycero-3-phosphoserine (1)
1-Palmitoyl-2-hydroxy-sn-glycero-3-PE (1)
3,4-Dihydroxyphenylacetic acid (1)
Cytidine 3',5'-cyclic monophosphate (1)
Thymidine monophosphate (1)
(R)-2-Hydroxyglutarate (1)
Adenylosuccinate (1)
Cadaverine (1)
Homocystine (1)
Cysteamine (1)
4-Hydroxybutyric acid (1)
Uridine 5'-diphosphogalactose (1)
Guanosine 3',5'-cyclic monophosphate (1)
Cysteine (1)
Histidine (1)
2-Ketoglutaric acid (1)
Beta-Alanine (1)
Methionine sulfone (1)
Oxidized glutathione (1)
3-Methoxytyramine (1)
Symmetric dimethylarginine (1)
Leucine (1)
Dimethylglycine (1)
4-Hydroxyproline (1)

First Public Date

2025 (25)
2023 (23)
2026 (17)
2024 (10)
2021 (6)
2022 (5)
2020 (4)
2019 (3)
2018 (1)
2017 (1)

Modelling Approach

Ordinary differential equation model (2)

Study status

Not provided (1)

Lab affiliation

Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete (2)
University of Oxford (2)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom (1)
Department of Molecular Biology, Princeton University, US (1)
Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
Division of Cellular and Systems Medicine, School of Medicine, University of Dundee, UK. DD1 9SY (1)
Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; (1)
Institute for Advanced Research, Wenzhou Medical University, Wenzhou, Zhejiang, P.R. China. (1)
Karolinska Institutet, Department of Medicine Solna, Unit of Translational Immunology (1)
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan (1)
Laboratory for RNA Cancer Biology Department of Oncology, LKI, KU Leuven (1)
Prof. Sara Zanivan CRUK Beatson Institute Switchback road, Glasgow, UK G611BD (1)
Senior Postdoctoral Fellow Lew Laboratory Immunology Division The Walter and Eliza Hall Institute, Australia (1)
The Francis Crick Institute 1 Midland Road London NW1 1AT UK (1)
Wang Yiguang lab (1)
Wuhan University (1)

Keyword

Atezolizumab (1)
Antibodies (1)

IsPrivate

False (2)

Submitter Keywords

Immuno-oncology (2)

Study type

Transcription profiling by array (21)
RNA-seq of coding RNA from single cells (3)
RNA-seq of coding RNA (3)
Unknown experiment type (1)
RNA-seq of non coding RNA from single cells (1)
Antigen profiling (1)
RNA-seq of total RNA (1)
RNA-seq of non coding RNA (1)
Interventional (1)

Release Date

2022 (75)
2025 (63)
2023 (57)
2024 (56)
2021 (52)
2020 (41)
2019 (31)
2017 (29)
2016 (19)
2015 (19)
2014 (16)
2012 (14)
2018 (14)
2026 (12)
2013 (5)
2011 (4)
2009 (4)
2008 (4)
2010 (2)
2004 (1)

Location

France (1)
Spain (1)

Previous page
1 / 73
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 73
Next page

Sort by:

Relevance

Page size

Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling flux of the TCA cycle

To elucidate the function of oxidative phosphorylation (OxPhos) during B-cell differentiation we employ CD23Cre-driven expression of the dominant-negative K320E mutant of the mitochondrial helicase Twinkle (DNT). DNT-expression depletes mitochondrial DNA during B cell maturation, reduces the abun...

2026-08-21 | MTBLS4647 | MetaboLights

PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity

PRJNA1471142 | ENA

Autophagy Suppresses CD8+ T cell Anti-tumour Immunity

PRJNA483127 | ENA

Isaeva2008 - Modelling of Anti-Tumour Immune Response Immunocorrective Effect of Weak Centimetre Electromagnetic Waves

Modelling of anti-tumour immune response: Immunocorrective effect of weak centimetre electromagnetic waves O.G. Isaeva* and V.A. Osipov Bogoliubov Laboratory of Theoretical Physics, Joint Institute for Nuclear Research, Dubna, Moscow Region, Russia We formulate the dynamical model for the anti-tumo...

2024-09-02 | BIOMD0000000910 | BioModels

Immuno-oncology